Bora Pharmaceuticals engages in the development, manufacturing, and selling of branded, generic, and over-the-counter healthcare products.

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

6472

COM:BORA-CORP

Bora Pharmaceuticals

Last Close

793.00

21/11 05:30

Market Cap

86.08B

Beta: -

Volume Today

1.39M

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics